We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
ClinicalTrials.gov Menu

Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD (HONOR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03062540
Recruitment Status : Terminated (Stopped early due to inadequate separation on primary efficacy endpoint at Week 12 according to Interim Analysis conducted on the first 274 (50%) patients.)
First Posted : February 23, 2017
Last Update Posted : September 17, 2019
Premier Research Group plc
Information provided by (Responsible Party):
Tonix Pharmaceuticals, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : July 27, 2018
Actual Study Completion Date : July 27, 2018
Certification/Extension First Submitted : September 9, 2019